BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen K, Parry JJ, Rogers BE, Anderson CJ. Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. Nucl Med Biol 2012;39:187-97. [PMID: 22056254 DOI: 10.1016/j.nucmedbio.2011.08.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Hernandez Vargas S, AghaAmiri S, Ghosh SC, Luciano MP, Borbon LC, Ear PH, Howe JR, Bailey-Lundberg JM, Simonek GD, Halperin DM, Tran Cao HS, Ikoma N, Schnermann MJ, Azhdarinia A. High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Mol Pharm 2022;19:4241-53. [PMID: 36174110 DOI: 10.1021/acs.molpharmaceut.2c00583] [Reference Citation Analysis]
2 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Abiraj K, Ursillo S, Tamma ML, Rylova SN, Waser B, Constable EC, Fani M, Nicolas GP, Reubi JC, Maecke HR. The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist. EJNMMI Res 2018;8:75. [PMID: 30069789 DOI: 10.1186/s13550-018-0428-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
4 Bandara N, Jacobson O, Mpoy C, Chen X, Rogers BE. Novel Structural Modification Based on Evans Blue Dye to Improve Pharmacokinetics of a Somastostatin-Receptor-Based Theranostic Agent. Bioconjug Chem 2018;29:2448-54. [PMID: 29927587 DOI: 10.1021/acs.bioconjchem.8b00341] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
5 Okarvi SM, Maecke HR. Radiolabelled peptides in medical imaging. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Elsevier; 2018. pp. 431-83. [DOI: 10.1016/b978-0-08-100736-5.00019-3] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
6 Marciniak A, Brasuń J. Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem 2017;313:279-89. [PMID: 28804185 DOI: 10.1007/s10967-017-5323-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
7 Okarvi SM, Maecke HR. Radiometallo-Labeled Peptides in Tumor Diagnosis and Targeted Radionuclide Therapy. Insights from Imaging in Bioinorganic Chemistry. Elsevier; 2016. pp. 341-96. [DOI: 10.1016/bs.adioch.2015.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Fani M, Maecke HR. Radiolabeled Somatostatin Receptor Antagonists. Somatostatin Analogues 2015. [DOI: 10.1002/9781119031659.ch27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Litau S, Seibold U, Vall-Sagarra A, Fricker G, Wängler B, Wängler C. Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments. ChemMedChem 2015;10:1200-8. [PMID: 26011290 DOI: 10.1002/cmdc.201500132] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
10 Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Mol Imaging Biol 2014;16:567-77. [PMID: 24448825 DOI: 10.1007/s11307-013-0717-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
11 Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging 2014;13. [PMID: 25060207 DOI: 10.2310/7290.2014.00020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
12 Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem 2014;57:6019-29. [PMID: 24983404 DOI: 10.1021/jm500416f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
13 Paterson BM, Roselt P, Denoyer D, Cullinane C, Binns D, Noonan W, Jeffery CM, Price RI, White JM, Hicks RJ, Donnelly PS. PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Trans 2014;43:1386-96. [PMID: 24202174 DOI: 10.1039/c3dt52647j] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
14 Wang Z, Ma W, Wang J, Deng J, Yuan M, Zhao M, Jia L, Yang W, Zhang R, Qin W, Chu D, Li G. Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs. Tumor Biol 2013;34:2451-7. [DOI: 10.1007/s13277-013-0796-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Urch DS. Radiochemistry. Annu Rep Prog Chem , Sect A: Inorg Chem 2013;109:468. [DOI: 10.1039/c3ic90028b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Toyota T, Hanafusa T, Oda T, Koumura I, Sasaki T, Matsuura E, Kumon H, Yano T, Ono T. A purification system for 64Cu produced by a biomedical cyclotron for antibody PET imaging. J Radioanal Nucl Chem 2013;298:295-300. [PMID: 26224937 DOI: 10.1007/s10967-012-2340-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
17 Bailey GA, Price EW, Zeglis BM, Ferreira CL, Boros E, Lacasse MJ, Patrick BO, Lewis JS, Adam MJ, Orvig C. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorg Chem 2012;51:12575-89. [PMID: 23106422 DOI: 10.1021/ic302225z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
18 Weeks AJ, Blower PJ, Lloyd DR. p53-dependent radiobiological responses to internalised indium-111 in human cells. Nucl Med Biol 2013;40:73-9. [PMID: 23062949 DOI: 10.1016/j.nucmedbio.2012.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Wang X, Fani M, Schulz S, Rivier J, Reubi JC, Maecke HR. Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy. Eur J Nucl Med Mol Imaging 2012;39:1876-85. [DOI: 10.1007/s00259-012-2231-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]